• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素长期治疗隐孢子虫病及出现鸟分枝杆菌引起的耐药播散性感染:病例报告

Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report.

作者信息

Matteelli A, Signorini L, Tebaldi A, Bombana E, Chatel G, Pinsi G

机构信息

Clinic of Infectious and Tropical Diseases-University of Brescia, Italy.

出版信息

J Chemother. 1998 Dec;10(6):474-5. doi: 10.1179/joc.1998.10.6.474.

DOI:10.1179/joc.1998.10.6.474
PMID:9876056
Abstract

Macrolide resistance in disseminated Mycobacterium avium infection is of major concern in AIDS patients as these drugs represent the main component of combination therapy. Clarithromycin and azithromycin should not be used alone for the treatment and prophylaxis of the disease because of the risk of selecting resistant strains. We report the case of a clarithromycin resistant disseminated M. avium infection in an AIDS patient, acquired after long term monotherapy with clarithromycin for the treatment of cryptosporidiosis.

摘要

在播散性鸟分枝杆菌感染中,大环内酯类耐药性是艾滋病患者主要关注的问题,因为这些药物是联合治疗的主要组成部分。由于存在选择耐药菌株的风险,克拉霉素和阿奇霉素不应单独用于该疾病的治疗和预防。我们报告了一例艾滋病患者发生克拉霉素耐药的播散性鸟分枝杆菌感染病例,该患者在长期使用克拉霉素单药治疗隐孢子虫病后感染。

相似文献

1
Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report.克拉霉素长期治疗隐孢子虫病及出现鸟分枝杆菌引起的耐药播散性感染:病例报告
J Chemother. 1998 Dec;10(6):474-5. doi: 10.1179/joc.1998.10.6.474.
2
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.从接受含克拉霉素治疗方案的艾滋病患者中分离出的克拉霉素敏感和耐药鸟分枝杆菌菌株的比较。
J Infect. 2000 Jan;40(1):49-54. doi: 10.1053/jinf.1999.0539.
3
[Azithromycin and Mycobacterium avium infection].[阿奇霉素与鸟分枝杆菌感染]
Pathol Biol (Paris). 1995 Jun;43(6):565-7.
4
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.克拉霉素或利福布汀单独或联合用于艾滋病患者鸟分枝杆菌复合群疾病的一级预防:一项随机、双盲、安慰剂对照试验。艾滋病临床试验组196/特里·贝恩艾滋病临床研究社区项目009方案团队。
J Infect Dis. 2000 Apr;181(4):1289-97. doi: 10.1086/315380. Epub 2000 Apr 13.
5
Clarithromycin against Mycobacterium avium complex infections.克拉霉素治疗鸟分枝杆菌复合群感染
Tuber Lung Dis. 1996 Feb;77(1):19-26. doi: 10.1016/s0962-8479(96)90070-2.
6
Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.接受克拉霉素或阿奇霉素预防鸟分枝杆菌复合体感染的HIV感染患者呼吸道菌群中存在大环内酯类耐药性。
HIV Clin Trials. 2001 Nov-Dec;2(6):453-9. doi: 10.1310/13GY-1LBY-355N-89HF.
7
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.一项关于克拉霉素预防晚期获得性免疫缺陷综合征患者播散性鸟分枝杆菌复合体感染的随机试验。
N Engl J Med. 1996 Aug 8;335(6):384-91. doi: 10.1056/NEJM199608083350603.
8
Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.克拉霉素预防艾滋病患者隐孢子虫肠炎。
J Natl Med Assoc. 1996 Jul;88(7):425-7.
9
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.克拉霉素及其他抗菌药物治疗获得性免疫缺陷综合征患者播散性鸟分枝杆菌感染
Arch Intern Med. 1993 Feb 8;153(3):368-72.
10
Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.实验性化疗期间对大环内酯类耐药的鸟分枝杆菌菌群的出现
Antimicrob Agents Chemother. 1998 Jan;42(1):180-3. doi: 10.1128/AAC.42.1.180.